Editorial

From the desk of the editor

Welcome to the May 2013 edition of i2P - Information to pharmacists.
Economic turbulence seems to now be arriving in Australia with forecasts of high inflation rates, which also means high interest rates following on.
This type of economic forecast also means that banks will be more fractious with their borrowers. They are already offside with pharmacy due to the high level of bankruptcies over the past two years.
There is a pent up demand for a general wage increase for pharmacists impacting at a point in this month where pharmacy gross profit generally, is in decline.

read more
open full screen

Columns

Recent Comments

Click here to read...

Past Editions

Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4
Volume 4 Number 5
Volume 4 Number 6
Volume 4 Number 7
Volume 4 Number 8
Volume 4 Number 9
Volume 4 Number 10
Volume 4 Number 11
Volume 5 Number 1
Volume 5 Number 2
Volume 5 Number 3
Volume 5 Number 4

i2P Archives

Health Politics

EPublications

Click here for a list of epublications

ASMI Media Releases for April 2013

• Printer-friendly version
• Send to friend
• PDF version
• Share

	Michelle Sollit-Davis articles by this author...
Information and news from the Australian Self Medication Industry (ASMI) provided by Michelle Sollitt-Davis (ASMI PR Manager). Contact her on 02 9923 9410 or email michelle@asmi.com.au

The Australian Self-Medication Industry (ASMI) is the peak industry body for the Australian self care industry representing consumer healthcare products including over-the-counter medicines and complementary medicines. ASMI’s mission is to promote better health through responsible self-care. This means ensuring that safe and effective self-care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy. www.asmi.com.au

open this article full screen

 22 April 2013 –

New ASMI complementary medicines post to tackle growth hurdles
 

The Australian Self Medication Industry (ASMI) is ramping up its capability to meet the needs of the complementary medicines (CM) industry, with a new senior appointment to oversee the strategic direction of the sector.

ASMI Executive Director, Dr Deon Schoombie, today announced the appointment of Ms Brenda Davy to the newly created position of CM Strategy Manager, responsible for managing a range of strategic issues impacting the sector across the commercial, regulatory and consumer areas.

Ms Davy brings more than 20 years’ experience in management and strategic consulting roles in Australia, New Zealand, Canada and Asia, including recent experience as Global Category Marketing Manager at Blackmores and previously as Regional Marketing Director at Procter & Gamble.

Dr Schoombie said the appointment reflects the unique demands being placed on the sector as it manages exceptional growth and calls for tighter regulatory controls.

“The place of complementary medicines has never been so great, but at the same time, there is a level of scrutiny that is proving a significant challenge to firms and the industry, more generally.

“With this appointment, we are aiming to fill a need in the market for a strategic direction that can help to build a sustainable, evidence-based sector that has the trust and respect of all stakeholders, and most importantly, consumers.

“For ASMI, we recognise the need to add to our existing strengths to address what is certain to be an ongoing series of challenges facing the sector as the popularity and awareness of CMs continues to grow. I am delighted that we have someone with Brenda’s extensive background and experience to join the ASMI team at this critical time.”

Commenting on her appointment, Ms Davy said: “I am delighted to be taking up this exciting role at a most important time for the complementary medicines sector. Consumers and a growing number of practitioners have demonstrated their commitment to using complementary medicines. We need to work with all stakeholders to ensure a growing and profitable sector, and one in which consumers can have the utmost confidence.”

16 April 2013 –
ASMI congratulates Kos Sclavos on eight years at the helm of the Pharmacy Guild of Australia

The Australian Self Medication Industry (ASMI) today extended its appreciation and congratulations to Kos Sclavos, the outgoing national president of the Pharmacy Guild of Australia, for his outstanding commitment to the pharmacy profession and community pharmacy in Australia.

Mr Sclavos announced yesterday that, after eight years as national president, he will step down in October 2013. 

“Kos has been a progressive and influential leader and a strong driving force behind of number of industry initiatives aimed at improving the health of Australians,” said ASMI Executive Director Dr Deon Schoombie. 

“ASMI has worked with the Pharmacy Guild for many years on ways to entrench a powerful preventative health culture in the community, including the need for greater self care. In particular, we applaud Kos for his collaborative approach in managing issues impacting the over-the-counter and complementary medicines industry.

“Among his many significant achievements, Kos is to be congratulated for taking the pharmacy profession into the digital era, with successful initiatives such as eHealth and electronic prescriptions and Project Stop to track sales of pseudoephedrine.”

Clinical Newsfeed

Click here to read more...

Research Reports

Practice Development

Preventive Medicine

i2P Alliance Partners